The Global Market for Molecular Diagnostics Infectious Disease 2021-2025
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With COVID-19 Impact & Forecasting/Analysis, and Executive Guides 2021 - 2025" report has been added to ResearchAndMarkets.com's offering.
COVID-19 drives a surge in demand but what is the long term impact? The microbiology lab my disappear while multiplex takes center stage.
The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing but is spiking as an enormous C19Dx demand sweeps over the globe. Find out what the numbers are in this informative report, and find out about the exciting developments in multiplex assays which threaten to change diagnosis and treatment while limiting the threat of antimicrobial drug resistance.
Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. A range of dynamic trends is pushing market growth and company valuations.
Trends like:
multiplex testing
pathogen evolution and pandemics
biotechnology advances in genetics
climate change
globalization
the rise of rapid testing
Exciting technical developments especially in the seesaw between nucleic acid testing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.
The report has hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help sharpen your pricing. The report includes detailed breakouts for 15 Countries and 4 Regions.
Key Topics Covered:
1. Introduction and Market Definition
2. The Infectious Diseases - Market Analysis by Disease
2.1 HIV - Human Immunodeficiency Virus (AIDS)
2.2 HBV - Hepatitis B
2.3 HCV - Hepatitis C
2.4 HPV - Human papillomavirus
2.5 Influenza
2.6 CTGC - Chlamydia/Gonorrhoea
2.7 Tuberculosis
2.8 MRSA - Methicillin-resistant Staphylococcus aureus
2.9 VRE - Vancomycin-resistant Enterococcus
2.10 Blood Screening
2.11 COVID-19
2.12 Pandemic Diagnostics
3. Industry Overview
3.1 Players in a Dynamic Market
3.2 The Clinical Laboratory Market Segments
3.3 Industry Structure
3.4 Profiles of Key MDx Companies
4. Market Trends
4.1 Factors Driving Growth
4.2 Factors Limiting Growth
4.3 Instrumentation and Automation
4.4 Diagnostic Technology Development
5. Molecular Dx - Infectious Disease Recent Developments
6. The Global Market for Molecular Diagnostics Infectious Disease
6.1 Global Market Overview by Country
6.2 Global Market by Syndrome - Overview
6.3 Global Market by Plex - Overview
6.4 Global Market by Place - Overview
7. Global MDx Infectious Disease Markets - By Syndrome
8. Global MDx Markets for Infectious Disease - by Plex
9. Global MDx Infectious Disease Markets - by Place
Appendices
I. United States Medicare System: 2020 Clinical Laboratory Fees Schedule
II. COVID-19 Approved Assays
Companies Mentioned
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akonni Biosystems
Alveo Technologies
Applied BioCode
Atlas Genetics
Aus Diagnostics
BD Diagnostics
Beckman Coulter
Bio-Rad Laboratories
Biocartis
bioMerieux
Bosch Healthcare Solutions GmbH
Cepheid
Chembio
Curetis
Diagenode Diagnostics
DiaSorin
Eiken Chemical
Fusion Genomics
Genedrive
GenePOC Diagnostics
GenMark Dx
Grifols
Hologic
Illumina
Inflammatix
Janssen Diagnostics
Karius
Lexagene
Luminex
Mbio Diagnostics
Meridian Bioscience
Mesa Biotech
Mobidiag
Nanomix
Oxford Nanopore Technologies
Panagene
Primerdesign
Prominex
Qiagen
Quantumdx
Quidel
Roche Molecular Diagnostics
Seegene
Siemens Healthineers
SpeeDx
T2 Biosystems
Thermo Fisher
Veramarx
XCR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/5iegyr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900